Recurrence-free survival by NAMPT IHC score.
- Katelynn Davis (6444029)
- Craig D. Dunseth (6444032)
- Sarah L. Mott (6444035)
- Kimberly L. Cramer-Morales (6444038)
- Ann M. Miller (6444041)
- Po Hien Ear (6444044)
- James J. Mezhir (499018)
- Andrew M. Bellizzi (6444047)
- Carlos H. F. Chan (37435)
Publication date
March 2019
DOI Publisher
Public Library of Science (PLoS)Abstract
Kaplan-Meier curves showing recurrence-free survival of patients with NAMPT+ (blue line) and NAMPT- (red line) PDA. Median OS: 12.0 months (NAMPT+) vs. 13.5 months (NAMPT-); P-value: 0.34.</p
Add to ORKG